1)World Health Organization: Global tuberculosis report 2021 https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021(最終閲覧日:2022年3月11日)
2)Thwaites GE, van Toorn R, Schoeman J: Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 12: 999-1010, 2013
3)Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, et al: Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect 10: 803-812, 2010
4)Takahashi T, Tamura M, Takasu T: The PCR-based diagnosis of central nervous system tuberculosis: up to date. Tuberc Res Treat 2012: 831292, 2012[doi: 10.1155/2012/831292]
5)Verdon R, Chevret S, Laissy JP, Wolff M: Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 22: 982-988, 1996
6)Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, et al: Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68: 289-299, 2000
7)Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, et al: British infection society: British infection society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59: 167-187, 2009
8)日本結核病学会治療委員会: 「結核医療の基準」の改訂—2018年. 結核93: 61-68, 2018
9)Cohen DB, Zijlstra EE, Mukaka M, Reiss M, Kamphambale S, et al: Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health 15: 910-917, 2010
10)Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, et al: Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21: 803-809, 2002
11)Garg RK, Malhotra HS, Kumar N: Paradoxical reaction in HIV negative tuberculous meningitis. J Neurol Sci 340: 26-36, 2014
12)Lees AJ, MacLeod AF, Marshall J: Cerebral tuberculomas developing during treatment of tuberculous meningitis. Lancet 1: 1208-1211, 1980